BORELLA, MIRIAM
 Distribuzione geografica
Continente #
AS - Asia 155
NA - Nord America 155
EU - Europa 145
SA - Sud America 10
AF - Africa 5
OC - Oceania 2
Totale 472
Nazione #
US - Stati Uniti d'America 155
RU - Federazione Russa 63
CN - Cina 62
SG - Singapore 42
IT - Italia 24
KR - Corea 19
HK - Hong Kong 18
DE - Germania 13
BR - Brasile 10
FI - Finlandia 8
FR - Francia 8
IE - Irlanda 8
SE - Svezia 6
GB - Regno Unito 4
NL - Olanda 4
ID - Indonesia 3
IN - India 3
JO - Giordania 3
VN - Vietnam 3
ZA - Sudafrica 3
AU - Australia 2
CH - Svizzera 2
AE - Emirati Arabi Uniti 1
BJ - Benin 1
ES - Italia 1
GR - Grecia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TR - Turchia 1
UA - Ucraina 1
Totale 472
Città #
Santa Clara 66
Singapore 35
Ashburn 30
Hefei 24
Seoul 19
Hong Kong 16
Munich 10
Dublin 8
Florence 8
Beijing 5
Los Angeles 5
Moscow 4
Paris 4
Turku 4
Dallas 3
Fairfield 3
Helsinki 3
Jakarta 3
Kent 3
Altamura 2
Buffalo 2
Chandler 2
Frankfurt am Main 2
Lawrence 2
London 2
Melbourne 2
Montepiano 2
Mumbai 2
New York 2
Shanghai 2
Amsterdam 1
Athens 1
Baoding 1
Bengaluru 1
Bern 1
Boardman 1
Brakpan 1
Bratislava 1
Cambridge 1
Cape Town 1
Charlotte 1
Chicago 1
Cotonou 1
Dakar 1
Dubai 1
Falkenstein 1
Guadalupe 1
Hortolândia 1
Houston 1
Jaú 1
Johannesburg 1
Lappeenranta 1
Medford 1
Milan 1
Niterói 1
Phoenix 1
Poplar 1
Princeton 1
Queen Creek 1
Recife 1
Reginópolis 1
Roubaix 1
Siena 1
Southwark 1
St Louis 1
Suffern 1
São José do Divino 1
São Paulo 1
Teresina 1
Thái Bình 1
Valparaíso de Goiás 1
Washington 1
Wilmington 1
Woodbridge 1
Xingtai 1
Zurich 1
Totale 321
Nome #
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis 137
Humoral and cellular responses after third dose of SARS-CoV-2 vaccine in myeloproliferative neoplasms patients on ruxolitinib therapy 134
Impaired response to first SARS-CoV-2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib 122
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib 88
Totale 481
Categoria #
all - tutte 1.515
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.515


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202215 0 9 0 0 0 2 0 0 1 0 2 1
2022/202335 2 5 2 3 0 6 5 1 5 3 2 1
2023/202440 3 5 4 2 1 1 1 9 2 3 5 4
2024/2025226 7 16 10 27 52 39 11 9 8 7 20 20
2025/2026165 36 44 43 18 23 1 0 0 0 0 0 0
Totale 481